Publication | Closed Access

Carcinogenicity study of CKD-501, a novel dual peroxisome proliferator-activated receptors α and γ agonist, following oral administration to Sprague Dawley rats for 94–101weeks

MedicineCancer Cell BiologySprague Dawley RatsToxicologyPharmacotherapyExperimental Pharmacologyγ AgonistPharmacologyRadiation OncologyCarcinogenicity StudyCancer ResearchToxicological Mechanism